AtonRa Partners’s Guardant Health GH Stock Holding History

AtonRa Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$253K	Sell	9,348 -408	-4%	-$10.7K	0.5%	89
2023 Q3	$289K	Sell	9,756 -745	-7%	-$26.2K	0.61%	79
2023 Q2	$376K	Sell	10,501 -1,399	-12%	-$40.2K	0.58%	79
2023 Q1	$279K	Sell	11,900 -1,673	-12%	-$47.8K	0.41%	108
2022 Q4	$369K	Sell	13,573 -5,177	-28%	-$237K	0.47%	92
2022 Q3	$1.01M	Sell	18,750 -1,760	-9%	-$90.4K	0.99%	41
2022 Q2	$827K	Sell	20,510 -22,890	-53%	-$1.13M	0.76%	58
2022 Q1	$2.88M	Sell	43,400 -10,763	-20%	-$737K	1.56%	13
2021 Q4	$5.42M	Buy	54,163 +8,926	+20%	+$923K	1.88%	8
2021 Q3	$5.66M	Buy	45,237 +4,601	+11%	+$547K	1.89%	7
2021 Q2	$5.05M	Sell	40,636 -22,142	-35%	-$2.98M	1.85%	6
2021 Q1	$9.58M	Buy	62,778 +5,074	+9%	+$767K	4.27%	1
2020 Q4	$7.44M	Buy	+57,704	New	+$6.64M	3.65%	1

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

AtonRa Partners's GH Position: Q4 2023 in Review

AtonRa Partners reduced its Guardant Health (GH) stake by 4.2% in Q4 2023, selling an estimated $10.7K and leaving 9,348 shares worth $253K. The position accounts for 0.5% of the portfolio, ranked #89.

AtonRa Partners first reported a position in GH in Q4 2020 and has held it in 13 quarters since. The position peaked at $9.58M in Q1 2021. 294 funds tracked by Wall St. Rank hold GH as of Q4 2023.

AtonRa Partners held 9,348 shares of Guardant Health worth $253K as of Q4 2023.
AtonRa Partners sold 408 Guardant Health shares in Q4 2023, an estimated $10.7K.
Guardant Health made up 0.5% of AtonRa Partners's portfolio in Q4 2023, its #89 holding.
AtonRa Partners first reported a position in Guardant Health in Q4 2020 and has held it in 13 quarters since.
AtonRa Partners's Guardant Health position peaked at $9.58M in Q1 2021.
294 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.